Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Routier

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 18, 2024
Fatal myasthenia gravis (MG) associated with myositis and myocarditis in a patient with pre-existing MG treated by adjuvant nivolumab for a stage III melanomaJeanne Emile, Cécile Cauquil, Dorothée Carpentier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2023
Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologistMarie Boileau, Emilie Routier, Arnaud Pouvelle, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2023
Immune checkpoint inhibitors-associated myocarditis without cardiovascular symptomsJonathan Abitbol, Anais Vallet, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reportsAudrey Melin, Emilie Routier, Hubert Tissot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
Mitochondrial myopathy associated with anti-programmed cell death 1 therapyTony Ibrahim, Clovis Adam, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2017
Successful re-challenge with anti-BRAF and anti-MEK in a patient with symptomatic melanoma flareTony Ibrahim, Emilie Routier, Amadine Weill, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2022
Severe ototoxicity associated with immune checkpoint inhibitors (ICI) in advanced melanomaCeline Boutros, Etienne Peres, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2021
Refractive changes during immunotherapy: Think diabetes!Erwin Benassaia, Jean-Pierre Riveline, Emilie Routier, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Metastatic melanoma: New paradigms of treatment and new toxicitiesCaroline Robert, Christina Mateus, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2018
Arterial thrombosis and anti-PD-1 blockadeCéline Boutros, Jean-Yves Scoazec, Christine Mateus, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|May 18, 2024
Fatal myasthenia gravis (MG) associated with myositis and myocarditis in a patient with pre-existing MG treated by adjuvant nivolumab for a stage III melanomaJeanne Emile, Cécile Cauquil, Dorothée Carpentier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2023
Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologistMarie Boileau, Emilie Routier, Arnaud Pouvelle, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2023
Immune checkpoint inhibitors-associated myocarditis without cardiovascular symptomsJonathan Abitbol, Anais Vallet, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reportsAudrey Melin, Emilie Routier, Hubert Tissot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
Mitochondrial myopathy associated with anti-programmed cell death 1 therapyTony Ibrahim, Clovis Adam, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2017
Successful re-challenge with anti-BRAF and anti-MEK in a patient with symptomatic melanoma flareTony Ibrahim, Emilie Routier, Amadine Weill, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2022
Severe ototoxicity associated with immune checkpoint inhibitors (ICI) in advanced melanomaCeline Boutros, Etienne Peres, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2021
Refractive changes during immunotherapy: Think diabetes!Erwin Benassaia, Jean-Pierre Riveline, Emilie Routier, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Metastatic melanoma: New paradigms of treatment and new toxicitiesCaroline Robert, Christina Mateus, Emilie Routier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2018
Arterial thrombosis and anti-PD-1 blockadeCéline Boutros, Jean-Yves Scoazec, Christine Mateus, et al.
Pageof 5